Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/CLIM.1998.4615PMID 9884360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High antibody response to autologous type II collagen is restricted to H-2q

  2004cited by this paper
• Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

  1998cited by this paper
• Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.

  1998cited by this paper
• An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen

  1997cited by this paper
• Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

  1997cited by this paper
• Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139‐151 peptide

  1996cited by this paper
• Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

  1996cited by this paper
• Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes.

  1996cited by this paper
• Mucosal tolerance and suppression of collagen‐induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184‐198 of bovine type II collagen (CII) expressing a dominant T cell epitope

  1996cited by this paper
• Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

  1996cited by this paper
• Late Complications of Immune Deviation Therapy in a Nonhuman Primate

  1996cited by this paper
• Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

  1996cited by this paper
• Specificity of an HLA‐DRB1*0401‐restricted T cell response to type II collagen

  1996cited by this paper
• Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide.

  1996cited by this paper
• Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial.

  1996cited by this paper
• Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen.

  1995cited by this paper
• "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins.

  1994cited by this paper
• Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouse

  1994cited by this paper
• Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response.

  1994cited by this paper
• An ear swelling reaction for in vivo monitoring of inflammatory T cell activity in collagen-arthritic rats.

  1994cited by this paper
• Effects of oral administration of type II collagen on rheumatoid arthritis.

  1993cited by this paper
• Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.

  1993cited by this paper
• Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression.

  1993cited by this paper
• Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis.

  1992cited by this paper
• Homologous collagen‐induced arthritis in ratg and mice are associated with structurally different major histocompatibility complex DQ‐like molecules

  1992cited by this paper
• Antigen-driven bystander suppression after oral administration of antigens

  1991cited by this paper
• Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.

  1990cited by this paper
• Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis.

  1989cited by this paper
• Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

  1989cited by this paper
• Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

  1986cited by this paper
• Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.

  1986cited by this paper
• Preparation and characterization of the different types of collagen.

  1982cited by this paper
• Anti-cartilage antibody.

  1979cited by this paper
• Nature of the collagen synthesized by a transplanted chondrosarcoma.

  1975cited by this paper

• Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models

  2021cites this paper
• Sex differences in Tfh cell help to B cells contribute to sexual dimorphism in severity of rat collagen-induced arthritis

  2020cites this paper
• Animal Models in Lupus

  2019cites this paper
• Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.

  2018cites this paper
• Chapter 29 – Experimental Models for Rheumatoid Arthritis

  2017cites this paper
• Long-Term Effects of (–)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats

  2016influential citation
• Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis

  2015cites this paper
• Chapter 17 – Animal Models of SLE

  2013cites this paper
• 28 – Experimental Models for Rheumatoid Arthritis

  2013cites this paper
• EFFECT OF COCCULUS HIRSUTUS LEAVES EXTRACT ON FREUNDS COMPLETE ADJUVANT AND FORMALDEHYDE INDUCED AR T HRITIS

  2012cites this paper
• Studies on Understanding the Pathogenic Mechanisms in Arthritis Experiments Using Joining chain deficient (J-/-) and Ncf1 gene mutated B6N mice

  2012cites this paper
• The Impact of a Germ Free Perinatal Period on the Variation in Animal Models of Human Inflammatory Diseases - A Review

  2010cites this paper
• Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

  2009cites this paper
• The structure and function of normal and mutated collagen IX

  2007cites this paper
• Genetic Regulation of T Regulatory, CD4, and CD8 Cell Numbers by the Arthritis Severity Loci Cia5a, Cia5d, and the MHC/Cia1 in the Rat

  2007cites this paper
• Oral Tolerance: Therapeutic Implications for Autoimmune Diseases

  2006cites this paper
• Dissection of the genetic complexity of arthritis using animal models.

  2006cites this paper
• Chemical-Induced Animal Models of Human Autoimmunity

  2005cites this paper
• Murine lupus induced by tetramethylpentadecane: an animal model of systemic human autoimmunity.

  2005cites this paper
• Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicam.

  2004cites this paper
• Immune reactivity to connective tissue antigens in pristane induced arthritis.

  2004cites this paper
• Dissection of the genetic complexity of arthritis using animal models.

  2003cites this paper
• Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen.

  2002cites this paper
• Immunogenicity of recombinant type IX collagen in murine collagen-induced arthritis.

  2002cites this paper
• Extra‐articular cartilage affected in collagen‐induced, but not pristane‐induced, arthritis models

  2002cites this paper
• Arthritis induced in rats with non‐immunogenic adjuvants as models for rheumatoid arthritis

  2001cites this paper
• Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen

  2001cites this paper
• Elucidation of pathways leading to rheumatoid arthritis by genetic analysis of animal models.

  2001cites this paper
• SP0007 Osteoarthritis: new concepts of pathogenesis and management guidelines

  2001cites this paper
• Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.

  1999cites this paper
• Oral tolerance: mechanisms and therapeutic applications.

  1999cites this paper